60.61
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Is Disc Medicine Inc. a growth stock or a value stockSkyrocketing profit margins - jammulinksnews.com
What is the dividend policy of Disc Medicine Inc. stockGet exclusive market insights for better trading - jammulinksnews.com
Should I hold or sell Disc Medicine Inc. stock in 2025Discover high-impact investment opportunities - jammulinksnews.com
How strong is Disc Medicine Inc. company’s balance sheetBuild wealth faster with expert stock picks - jammulinksnews.com
Insider Selling at Disc Medicine Inc.: A Balancing Act Between Portfolio Strategy and Investor Sentiment - AInvest
Is Disc Medicine Inc. a good long term investmentFree Stock Movement Tracking - PrintWeekIndia
Can Disc Medicine Inc. stock recover from recent declineSuperior profit margins - jammulinksnews.com
What drives Disc Medicine Inc. stock priceBreakthrough capital growth - PrintWeekIndia
10 Best Mid Cap Stocks to Buy According to Billionaires - Insider Monkey
Is Disc Medicine Inc. stock overhyped or has real potentialBreakthrough wealth creation - jammulinksnews.com
Disc Medicine Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - Autocar Professional
What analysts say about Disc Medicine Inc. stockUnrivaled growth potential - Autocar Professional
Disc Medicine’s Strategic Advancements and Regulatory Progress Drive Buy Rating - TipRanks
Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder - Nasdaq
Disc Medicine’s (IRON) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Disc Medicine's NDA Submission for Bitopertin in EPP: A Catalyst-Driven Opportunity in a High-Unmet-Need Market - AInvest
Disc Medicine to submit NDA for bitopertin in EPP in October By Investing.com - Investing.com India
Truist Securities initiates Disc Medicine stock with Buy rating, $86 target - Investing.com Canada
Disc Medicine to submit NDA for bitopertin in EPP in October - Investing.com Australia
Disc Medicine, Inc. Receives Positive FDA Feedback for Bitopertin NDA Submission in Erythropoietic Protoporphyria - Nasdaq
Disc Medicine Announces Positive Pre-NDA Meeting and - GlobeNewswire
why disc medicine inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Disc Medicine(IRON) Soars 7.28% on Insider Trading, Analyst Rating - AInvest
Disc medicine CFO Franchi sells $119k in shares - Investing.com
Disc medicine CFO Franchi sells $119k in shares By Investing.com - Investing.com India
Raymond James reiterates Strong Buy on Disc Medicine stock amid Bristol Myers trial results - Investing.com Canada
Why Disc Medicine Inc. stock attracts strong analyst attentionMarket Ready Callouts - Newser
How Disc Medicine Inc. stock performs during market volatilityCapital Safe Stock Watchlist - Newser
What makes Disc Medicine Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Disc Medicine Elects Nadim Ahmed as Director - The Globe and Mail
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):